{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:13:40Z","timestamp":1793168020198,"version":"4.5.0"},"reference-count":273,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017564","name":"Qmed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PR161603"],"award-info":[{"award-number":["PR161603"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01 HL649141"],"award-info":[{"award-number":["U01 HL649141"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL153500"],"award-info":[{"award-number":["R01 HL153500"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32 HL069751"],"award-info":[{"award-number":["T32 HL069751"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-068163"],"award-info":[{"award-number":["N01-HV-068163"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL090957"],"award-info":[{"award-number":["R01 HL090957"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-068161"],"award-info":[{"award-number":["N01-HV-068161"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-068162"],"award-info":[{"award-number":["N01-HV-068162"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R03 AG032631"],"award-info":[{"award-number":["R03 AG032631"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL151867"],"award-info":[{"award-number":["K23HL151867"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 HL125941"],"award-info":[{"award-number":["K23 HL125941"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01 HL064829"],"award-info":[{"award-number":["U01 HL064829"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL124649"],"award-info":[{"award-number":["R01 HL124649"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 HL105787"],"award-info":[{"award-number":["K23 HL105787"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U54 AG065141"],"award-info":[{"award-number":["U54 AG065141"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-068164"],"award-info":[{"award-number":["N01-HV-068164"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01 HL649241"],"award-info":[{"award-number":["U01 HL649241"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL146158"],"award-info":[{"award-number":["R01 HL146158"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 HL127262"],"award-info":[{"award-number":["K23 HL127262"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000124"],"award-info":[{"award-number":["UL1TR000124"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"Clinical Center","doi-asserted-by":"publisher","award":["MO1-RR00425"],"award-info":[{"award-number":["MO1-RR00425"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017007","name":"Adelson Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001796","name":"Gustavus and Louise Pfeiffer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009821","name":"Society for Women\u2019s Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009821","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012227","name":"Ladies Hospital Aid Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cardfail.2025.06.013","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T13:04:36Z","timestamp":1755090276000},"page":"75-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology"],"prefix":"10.1016","volume":"32","author":[{"given":"ANURADHA","family":"LALA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CRAIG","family":"BEAVERS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VANESSA","family":"BLUMER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LAPRINCESS","family":"BREWER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DIANA","family":"DE OLIVEIRA-GOMES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SANDRA B.","family":"DUNBAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HANNAH","family":"EVERY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RICHARD","family":"FERRARO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BONNIE","family":"KY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAMES L.","family":"JANUZZI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FRANCOISE","family":"MARVEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROBERT J.","family":"MENTZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ERIN","family":"MICHOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAGAT","family":"NARULA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KHURAM","family":"NASIR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PRADEEP","family":"NATARAJAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LORI ANN","family":"PETERSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FATIMA","family":"RODRIGUEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHAEL D.","family":"SHAPIRO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JENNA","family":"SKOWRONSKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RANDALL C.","family":"STARLING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PAM","family":"TAUB","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RYAN J.","family":"TEDFORD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QUENTIN","family":"YOUMANS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHELLEY","family":"ZIEROTH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARTHA","family":"GULATI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0001","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","article-title":"2025 Heart Disease and Stroke Statistics: A Report of US and Global Data from the American Heart Association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cardfail.2025.06.013_bib0002","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America","volume":"29","author":"Bozkurt","year":"2023","journal-title":"J Card Fail."},{"issue":"18","key":"10.1016\/j.cardfail.2025.06.013_bib0003","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0004","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jchf.2022.06.012","article-title":"Trends in heart failure-related mortality among older adults in the United States from 1999-2019","volume":"10","author":"Siddiqi","year":"2022","journal-title":"JACC Heart Fail"},{"issue":"24","key":"10.1016\/j.cardfail.2025.06.013_bib0005","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1161\/hc4901.102568","volume":"104","author":"Hunt","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0006","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ejhf.705","article-title":"Silent disease progression in clinically stable heart failure","volume":"19","author":"Sabbah","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0007","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0008","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J Card Fail"},{"issue":"21","key":"10.1016\/j.cardfail.2025.06.013_bib0009","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/01.CIR.98.21.2282","article-title":"Congestive heart failure in the community","volume":"98","author":"Senni","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0010","first-page":"152","article-title":"Classification of Heart Failure in the Atherosclerosis Risk in Communities (ARIC) Study","volume":"5","author":"Rosamond","year":"2012","journal-title":"Circulation: Heart Failure"},{"issue":"9921","key":"10.1016\/j.cardfail.2025.06.013_bib0011","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0012","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/heartjnl-2014-305697","article-title":"Heart failure risk prediction in the Multi-Ethnic Study of Atherosclerosis","volume":"101","author":"Chahal","year":"2015","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0013","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.cardfail.2025.06.013_bib0014","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/hrt.2011.225482","article-title":"Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study","volume":"97","author":"Butler","year":"2011","journal-title":"Heart"},{"issue":"19","key":"10.1016\/j.cardfail.2025.06.013_bib0015","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.jacc.2019.02.057","article-title":"10-Year risk equations for incident heart failure in the general population","volume":"73","author":"Khan","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.cardfail.2025.06.013_bib0016","first-page":"e484","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.cardfail.2025.06.013_bib0017","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0018","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","article-title":"The transition from hypertension to heart failure: contemporary update","volume":"5","author":"Messerli","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0019","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/hy1201.099615","article-title":"Cardiomyocyte apoptotic cell death in arterial hypertension","volume":"38","author":"Fortu\u00f1o","year":"2001","journal-title":"Hypertension."},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0020","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/hr.2011.39","article-title":"Oxidative stress and endothelial dysfunction in hypertension","volume":"34","author":"Schulz","year":"2011","journal-title":"Hypertension Research"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0021","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nature Reviews Cardiology"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0022","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","article-title":"The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure","volume":"20","author":"Packer","year":"1992","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.cardfail.2025.06.013_bib0023","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0024","article-title":"Effect of intensive blood pressure treatment on heart failure events in the Systolic Blood Pressure Reduction Intervention Trial","volume":"10","author":"Upadhya","year":"2017","journal-title":"Circulation: Heart Failure"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jama.1997.03550030052033","article-title":"Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group","volume":"278","author":"Kostis","year":"1997","journal-title":"JAMA"},{"issue":"9080","key":"10.1016\/j.cardfail.2025.06.013_bib0026","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet."},{"issue":"18","key":"10.1016\/j.cardfail.2025.06.013_bib0027","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0028","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/HJH.0000000000000848","article-title":"Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure\u2013meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J Hypertens"},{"issue":"10022","key":"10.1016\/j.cardfail.2025.06.013_bib0029","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.cardfail.2025.06.013_bib0030","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0031","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Yusuf","year":"1991","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.cardfail.2025.06.013_bib0032","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0033","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.cardfail.2025.06.013_bib0034","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0035","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0036","unstructured":"Prevention CfDCa. National Diabetes Statistics Report [Available at: https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html"},{"issue":"7","key":"10.1016\/j.cardfail.2025.06.013_bib0037","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","volume":"140","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0038","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cardfail.2021.10.006","article-title":"Sex Differences in Heart Failure","volume":"28","author":"Lala","year":"2022","journal-title":"J Card Fail"},{"issue":"22","key":"10.1016\/j.cardfail.2025.06.013_bib0039","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","article-title":"Glycemic control and heart failure among adult patients with diabetes","volume":"103","author":"Iribarren","year":"2001","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0040","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jchf.2021.06.005","article-title":"Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study","volume":"9","author":"Echouffo-Tcheugui","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"9","key":"10.1016\/j.cardfail.2025.06.013_bib0041","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.2337\/dc10-0286","article-title":"Diabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease: data from the Heart and Soul Study","volume":"33","author":"van Melle","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0042","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12933-021-01378-4","article-title":"Diabetes status-related differences in risk factors and mediators of heart failure in the general population: results from the MORGAM\/BiomarCaRE consortium","volume":"20","author":"Vuori","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0043","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jacc.2024.05.036","article-title":"The quest for understanding diabetic cardiomyopathy: can we preserve function and prevent failure?","volume":"84","author":"Lala","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0044","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jacc.2024.03.380","article-title":"Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy","volume":"84","author":"Januzzi","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.cardfail.2025.06.013_bib0045","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.cardfail.2025.06.013_bib0046","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0047","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.cardfail.2025.06.013_bib0048","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.cardfail.2025.06.013_bib0049","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2020.1906","article-title":"Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes","volume":"323","author":"Petrie","year":"2020","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.cardfail.2025.06.013_bib0050","first-page":"S158","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"37","key":"10.1016\/j.cardfail.2025.06.013_bib0051","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.cardfail.2025.06.013_bib0052","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0053","first-page":"1164","article-title":"JCS\/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure","volume":"31","author":"Kitai","year":"2025","journal-title":"Circ J"},{"issue":"14","key":"10.1016\/j.cardfail.2025.06.013_bib0054","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.cardfail.2025.06.013_bib0056","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.cardfail.2025.06.013_bib0057","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med."},{"issue":"23","key":"10.1016\/j.cardfail.2025.06.013_bib0058","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0059","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.kint.2022.06.013","article-title":"Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence","volume":"102","author":"Rossing","year":"2022","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1016\/j.cardfail.2025.06.013_bib0060","first-page":"S219","article-title":"11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0061","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.kint.2022.08.012","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"102","author":"de Boer","year":"2022","journal-title":"Kidney Int"},{"issue":"19","key":"10.1016\/j.cardfail.2025.06.013_bib0062","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0063","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0064","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0065","unstructured":"World Obesity Federation. World Obesity Atlas 2023. Available at: https:\/\/s3-eu-west-1.amazonaws.com\/wof-files\/World_Obesity_Atlas_2023_Report.pdf"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0066","unstructured":"Fryar CD, Carroll MD, Afful J. Prevalence of Overweight, Obesity, and Severe Obesity Among Adults Aged 20 and Over: United States, 1960\u20131962 Through 2017\u20132018. 2021. Available at: https:\/\/www.cdc.gov\/nchs\/data\/hestat\/obesity-adult-17-18\/obesity-adult.htm"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0067","first-page":"399","article-title":"Normal-weight central obesity: Unique hazard of the toxic waist","volume":"65","author":"Bosomworth","year":"2019","journal-title":"Can Fam Physician"},{"issue":"15","key":"10.1016\/j.cardfail.2025.06.013_bib0068","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/CIRCULATIONAHA.117.032474","article-title":"Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity","volume":"137","author":"Packer","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0069","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jchf.2013.01.006","article-title":"Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure","volume":"1","author":"Lavie","year":"2013","journal-title":"JACC Heart Fail"},{"issue":"13","key":"10.1016\/j.cardfail.2025.06.013_bib0071","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/eurheartj\/ehad083","article-title":"Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox","volume":"44","author":"Butt","year":"2023","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0072","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0073","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ehf2.12120","article-title":"Obesity paradox in heart failure: a heavy matter","volume":"3","author":"Nagarajan","year":"2016","journal-title":"ESC Heart Fail"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0074","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.hlc.2023.11.022","article-title":"The effect of weight loss through lifestyle interventions in patients with heart failure with preserved ejection fraction\u2013a systematic review and meta-analysis of randomised controlled trials","volume":"33","author":"Lee","year":"2024","journal-title":"Heart Lung Circ"},{"issue":"9","key":"10.1016\/j.cardfail.2025.06.013_bib0075","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/ejhf.3270","article-title":"Intentional weight loss in overweight and obese patients with heart failure: A systematic review","volume":"26","author":"Peck","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0076","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","article-title":"The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF","volume":"6","author":"Savji","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0077","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1016\/j.orcp.2013.12.005","article-title":"Mechanisms of heart failure in obesity","volume":"8","author":"Ebong","year":"2014","journal-title":"Obes Res Clin Pract"},{"issue":"21","key":"10.1016\/j.cardfail.2025.06.013_bib0078","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0079","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084215","article-title":"Obesity, Nutrition and Heart Rate Variability","volume":"22","author":"Str\u00fcven","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.cardfail.2025.06.013_bib0080","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2337\/dbi24-0029","article-title":"The relationship between cardiac energy metabolism and cardiac function in obesity and type 2 diabetes: revisiting a 2003 diabetes classic by Aasum et al","volume":"73","author":"Ussher","year":"2024","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.cardfail.2025.06.013_bib0081","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"issue":"10454","key":"10.1016\/j.cardfail.2025.06.013_bib0082","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(24)01498-3","article-title":"Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial","volume":"404","author":"Deanfield","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0083","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med."},{"issue":"24","key":"10.1016\/j.cardfail.2025.06.013_bib0084","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1016\/j.cardfail.2025.06.013_bib0085","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0086","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jacc.2022.10.028","article-title":"Albuminuria and heart failure: JACC state-of-the-art review","volume":"81","author":"Khan","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.cardfail.2025.06.013_bib0087","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0088","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC Investigators","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0089","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1001\/jamainternmed.2015.2691","article-title":"Longitudinal associations between neighborhood physical and social environments and incident type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"175","author":"Christine","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"24","key":"10.1016\/j.cardfail.2025.06.013_bib0090","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.cardfail.2025.06.013_bib0091","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1161\/01.CIR.0000146819.43235.A9","article-title":"Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials","volume":"110","author":"Young","year":"2004","journal-title":"Circulation"},{"issue":"9645","key":"10.1016\/j.cardfail.2025.06.013_bib0092","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0093","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCHEARTFAILURE.109.881805","article-title":"Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial","volume":"3","author":"Masson","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"9689","key":"10.1016\/j.cardfail.2025.06.013_bib0094","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(09)61378-7","article-title":"Albuminuria in chronic heart failure: prevalence and prognostic importance","volume":"374","author":"Jackson","year":"2009","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.cardfail.2025.06.013_bib0095","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0096","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2024.10.091","article-title":"Finerenone and kidney outcomes in patients with heart failure: The FINEARTS-HF Trial","volume":"85","author":"Mc Causland","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0097","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.cardfail.2025.06.013_bib0098","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0099","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.122.003704","article-title":"Prevalence and Disease Expression of Pathogenic and Likely Pathogenic Variants Associated With Inherited Cardiomyopathies in the General Population","volume":"15","author":"Bourfiss","year":"2022","journal-title":"Circ Genom Precis Med"},{"issue":"7","key":"10.1016\/j.cardfail.2025.06.013_bib0100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/jamacardio.2022.0901","article-title":"Association of pathogenic DNA variants predisposing to cardiomyopathy with cardiovascular disease outcomes and all-cause mortality","volume":"7","author":"Patel","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"364","key":"10.1016\/j.cardfail.2025.06.013_bib0101","doi-asserted-by":"crossref","first-page":"364ra151","DOI":"10.1126\/scitranslmed.aag2367","article-title":"Aggregate penetrance of genomic variants for actionable disorders in European and African Americans","volume":"8","author":"Natarajan","year":"2016","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0102","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jacc.2021.07.017","article-title":"Phenotypic expression and outcomes in individuals with rare genetic variants of hypertrophic cardiomyopathy","volume":"78","author":"de Marvao","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0103","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/CIRCULATIONAHA.121.058143","article-title":"Frequency, penetrance, and variable expressivity of dilated cardiomyopathy-associated putative pathogenic gene variants in UK biobank participants","volume":"146","author":"Shah","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0104","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCULATIONAHA.123.065987","article-title":"Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy","volume":"149","author":"Topriceanu","year":"2024","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.cardfail.2025.06.013_bib0105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/heartjnl-2021-320181","article-title":"Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study","volume":"108","author":"Brownrigg","year":"2022","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100866","article-title":"ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Miller","year":"2023","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0107","doi-asserted-by":"crossref","DOI":"10.1161\/HCG.0000000000000092","article-title":"Interpreting incidentally identified variants in genes associated with heritable cardiovascular disease: A scientific statement from the American Heart Association","volume":"16","author":"Landstrom","year":"2023","journal-title":"Circ Genom Precis Med"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0108","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic Evaluation of Cardiomyopathy\u2014A Heart Failure Society of America Practice Guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0109","first-page":"e93","article-title":"Polygenic risk scores for cardiovascular disease: a scientific statement from the American Heart Association","volume":"146","author":"O'Sullivan","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0110","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1038\/s41467-022-34216-6","article-title":"Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure","volume":"13","author":"Levin","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0111","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaccao.2024.04.010","article-title":"Use of polygenic risk score for prediction of heart failure in cancer survivors","volume":"6","author":"Soh","year":"2024","journal-title":"JACC CardioOncol"},{"issue":"12","key":"10.1016\/j.cardfail.2025.06.013_bib0112","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1038\/s41588-024-01952-y","article-title":"Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy","volume":"56","author":"Zheng","year":"2024","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.cardfail.2025.06.013_bib0113","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1038\/s41588-024-02047-4","article-title":"Publisher Correction: Genome-wide association study reveals mechanisms underlying dilated cardiomyopathy and myocardial resilience","volume":"56","author":"Jurgens","year":"2024","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.cardfail.2025.06.013_bib0114","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamacardio.2022.1061","article-title":"Rare and common genetic variation underlying the risk of hypertrophic cardiomyopathy in a national biobank","volume":"7","author":"Biddinger","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"37","key":"10.1016\/j.cardfail.2025.06.013_bib0115","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0116","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","article-title":"Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction","volume":"138","author":"Beale","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.cardfail.2025.06.013_bib0117","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archinternmed.2009.50","article-title":"Adverse Cardiovascular Outcomes in Women With Nonobstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project","volume":"169","author":"Gulati","year":"2009","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0118","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100980","article-title":"Pathophysiology of preeclampsia-induced vascular dysfunction and implications for subclinical myocardial damage and heart failure","volume":"3","author":"Shaw","year":"2024","journal-title":"JACC Adv"},{"issue":"9","key":"10.1016\/j.cardfail.2025.06.013_bib0119","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jchf.2023.03.021","article-title":"Pregnancy-induced hypertensive disorder and risks of future ischemic and nonischemic heart failure","volume":"11","author":"Mantel","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0120","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/HYPERTENSIONAHA.120.15654","article-title":"Heart failure in women with hypertensive disorders of pregnancy: insights from the Cardiovascular Disease in Norway Project","volume":"76","author":"Honigberg","year":"2020","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0121","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003497","article-title":"Preeclampsia and future cardiovascular health: a systematic review and meta-analysis","volume":"10","author":"Wu","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"13","key":"10.1016\/j.cardfail.2025.06.013_bib0122","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013991","article-title":"Future cardiovascular disease risk for women with gestational hypertension: a systematic review and meta-analysis","volume":"9","author":"Lo","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0123","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00125-019-4840-2","article-title":"Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis","volume":"62","author":"Kramer","year":"2019","journal-title":"Diabetologia"},{"issue":"24","key":"10.1016\/j.cardfail.2025.06.013_bib0124","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1136\/heartjnl-2015-307563","article-title":"Association between miscarriage and cardiovascular disease in a Scottish cohort","volume":"101","author":"Wagner","year":"2015","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0125","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006713","article-title":"Duration of reproductive life span, age at menarche, and age at menopause are associated with risk of cardiovascular disease in women","volume":"6","author":"Ley","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0126","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/2047487314556004","article-title":"Cardiovascular disease risk in women with premature ovarian insufficiency: A systematic review and meta-analysis","volume":"23","author":"Roeters van Lennep","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"14","key":"10.1016\/j.cardfail.2025.06.013_bib0127","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.115.020491","article-title":"Peripartum cardiomyopathy","volume":"133","author":"Arany","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0128","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.cardfail.2025.06.013_bib0130","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jacc.2013.08.717","article-title":"The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis","volume":"62","author":"Bello","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0131","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jacc.2019.11.014","article-title":"Peripartum cardiomyopathy: JACC state-of-the-art review","volume":"75","author":"Davis","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0132","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy","volume":"12","author":"Sliwa","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0133","article-title":"Bueno-Orovio A. Toward a broader view of mechanisms of drug cardiotoxicity","volume":"2","author":"Mamoshina","year":"2021","journal-title":"Cell Rep Med"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0134","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","article-title":"Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Page","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ejhf.2351","article-title":"Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology","volume":"24","author":"Piepoli","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0136","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jaccao.2023.04.006","article-title":"Cardio-oncology and health equity: opportunities for implementation","volume":"5","author":"Johnson","year":"2023","journal-title":"JACC CardioOncol"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0137","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaccao.2022.03.005","article-title":"Cardiometabolic comorbidities in cancer survivors: JACC: CardioOncology state-of-the-art review","volume":"4","author":"Zullig","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0138","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaccao.2023.07.002","article-title":"Tracing the pathways from cardiovascular disease to cancer: the unseen link","volume":"5","author":"Abraham","year":"2023","journal-title":"JACC CardioOncol"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0139","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2020.11.020","article-title":"Strain-guided management of potentially cardiotoxic cancer therapy","volume":"77","author":"Thavendiranathan","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.cardfail.2025.06.013_bib0140","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/CIRCULATIONAHA.123.064274","article-title":"Multicenter, prospective, randomized controlled trial of high-sensitivity cardiac troponin I-Guided combination angiotensin receptor blockade and beta-blocker therapy to prevent anthracycline cardiotoxicity: the Cardiac CARE Trial","volume":"148","author":"Henriksen","year":"2023","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0141","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaccao.2022.09.008","article-title":"The burden of uncontrolled cardiovascular risk factors in men with prostate cancer: a RADICAL-PC analysis","volume":"5","author":"Klimis","year":"2023","journal-title":"JACC CardioOncol"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0142","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaccao.2023.01.001","article-title":"Uncontrolled cardiovascular risk factors in prostate cancer patients: are we leaving too much on the table?","volume":"5","author":"Moningi","year":"2023","journal-title":"JACC CardioOncol"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0143","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaccao.2021.06.007","article-title":"Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification","volume":"3","author":"Bergom","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0144","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaccao.2022.01.093","article-title":"Deep inspiration breath hold and global longitudinal strain in women undergoing left-sided breast irradiation","volume":"4","author":"Ng","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaccao.2023.05.004","article-title":"Cardioprotection in patients at high risk of anthracycline-induced cardiotoxicity: JACC: CardioOncology primer","volume":"5","author":"Henriksen","year":"2023","journal-title":"JACC CardioOncol"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0146","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaccao.2022.01.101","article-title":"The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology state-of-the-art review","volume":"4","author":"Omland","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0147","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/ehjcvp\/pvad031","article-title":"Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines","volume":"9","author":"Thavendiranathan","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0148","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.2023.11887","article-title":"Atorvastatin for anthracycline-associated cardiac dysfunction: The STOP-CA randomized clinical trial","volume":"330","author":"Neilan","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0149","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cardfail.2024.08.045","article-title":"Cardio-oncology and heart failure: a scientific statement from the Heart Failure Society of America","volume":"31","author":"Bloom","year":"2025","journal-title":"J Card Fail."},{"issue":"Suppl 1","key":"10.1016\/j.cardfail.2025.06.013_bib0150","first-page":"S13","article-title":"New strategies and therapies for the prevention of heart failure in high-risk patients","volume":"45","author":"Hammond","year":"2022","journal-title":"Clin Cardiol"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0151","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.122.060881","article-title":"Leaving the social vacuum: expanding cardiovascular guidelines to embrace equity","volume":"146","author":"Magnani","year":"2022","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0152","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCRESAHA.121.319811","article-title":"Social determinants of cardiovascular disease","volume":"130","author":"Powell-Wiley","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0153","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2023.100609","article-title":"Preventing new-onset heart failure: Intervening at stage A","volume":"16","author":"Upadhya","year":"2023","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0154","first-page":"71","article-title":"Environmental exposures and cardiovascular disease: a challenge for health and development in low- and middle-income countries","volume":"35","author":"Burroughs Pena","year":"2017","journal-title":"Cardiol Clin"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0155","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.etap.2015.08.030","article-title":"Arsenic cardiotoxicity: an overview","volume":"40","author":"Alamolhodaei","year":"2015","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0156","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1289\/ehp.887891","article-title":"Cardiovascular actions of lead and relationship to hypertension: a review","volume":"78","author":"Kopp","year":"1988","journal-title":"Environ Health Perspect"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0157","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.envres.2009.12.004","article-title":"Cadmium exposure in association with history of stroke and heart failure","volume":"110","author":"Peters","year":"2010","journal-title":"Environ Res"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0158","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1289\/ehp.1509735","article-title":"Blood cadmium levels and incident cardiovascular events during follow-up in a population-based cohort of Swedish adults: the Malmo Diet and Cancer Study","volume":"124","author":"Barregard","year":"2016","journal-title":"Environ Health Perspect"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0159","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/CIRCULATIONAHA.123.064215","article-title":"Historical neighborhood redlining and cardiovascular risk in patients with chronic kidney disease","volume":"148","author":"Al-Kindi","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100375","article-title":"The role of the preventive cardiologist in addressing climate change","volume":"11","author":"Gulati","year":"2022","journal-title":"Am J Prev Cardiol"},{"issue":"14","key":"10.1016\/j.cardfail.2025.06.013_bib0161","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1001\/archinte.161.14.1725","article-title":"Depression and risk of heart failure among older persons with isolated systolic hypertension","volume":"161","author":"Abramson","year":"2001","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0162","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PSY.0000000000000027","article-title":"Association of anxiety disorders and depression with incident heart failure","volume":"76","author":"Garfield","year":"2014","journal-title":"Psychosom Med"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0163","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00006842-200201000-00002","article-title":"Depression and risk of heart failure among the elderly: a prospective community-based study","volume":"64","author":"Williams","year":"2002","journal-title":"Psychosom Med"},{"issue":"10","key":"10.1016\/j.cardfail.2025.06.013_bib0164","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101795","article-title":"Association of psychosocial risk factors and outcomes in heart failure: does COVID-19 affect outcomes?","volume":"48","author":"Kasireddy","year":"2023","journal-title":"Curr Probl Cardiol"},{"issue":"10","key":"10.1016\/j.cardfail.2025.06.013_bib0165","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1161\/CIR.0000000000000947","article-title":"Psychological health, well-being, and the mind-heart-body connection: a scientific statement from the American Heart Association","volume":"143","author":"Levine","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0166","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-publhealth-031912-114452","article-title":"Stress and cardiovascular disease: an update on current knowledge","volume":"34","author":"Steptoe","year":"2013","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0167","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002243","article-title":"Psychosocial Factors and Risk of Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis","volume":"9","author":"Ogilvie","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0168","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.5888\/pcd13.160088","article-title":"Chronic Disease Disparities by County Economic Status and Metropolitan Classification, Behavioral Risk Factor Surveillance System, 2013","volume":"13","author":"Shaw","year":"2016","journal-title":"Prev Chronic Dis"},{"issue":"17","key":"10.1016\/j.cardfail.2025.06.013_bib0169","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.119.041914","article-title":"The mind-heart-body connection","volume":"140","author":"Levine","year":"2019","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cardfail.2025.06.013_bib0170","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart Failure: an underappreciated complication of diabetes. a consensus report of the American Diabetes Association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.cardfail.2025.06.013_bib0171","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1161\/01.CIR.0000106903.98196.B6","article-title":"Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure","volume":"108","author":"Tang","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0172","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.0000112582.16683.EA","article-title":"Impact of obesity on plasma natriuretic peptide levels","volume":"109","author":"Wang","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0173","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.121.17323","article-title":"Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium","volume":"78","author":"Shin","year":"2021","journal-title":"Hypertension."},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0174","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jchf.2017.01.008","article-title":"Limited added value of circulating inflammatory biomarkers in chronic heart failure","volume":"5","author":"Nymo","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0175","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.cardfail.2025.06.013_bib0176","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.12.045","article-title":"Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study","volume":"55","author":"Kalogeropoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0177","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjcard.2021.11.045","article-title":"Inflammatory markers and risk of heart failure with reduced to preserved ejection fraction","volume":"167","author":"Albar","year":"2022","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0178","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jacc.2023.05.035","article-title":"C-reactive protein and risk of incident heart failure in patients with cardiovascular disease","volume":"82","author":"Burger","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0179","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cardfail.2023.10.024","article-title":"HERMES: effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation","volume":"30","author":"Petrie","year":"2024","journal-title":"J Card Fail"},{"issue":"10","key":"10.1016\/j.cardfail.2025.06.013_bib0180","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0181","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/cvr\/cvaa123","article-title":"Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase G\u03b1 oxidation","volume":"117","author":"Kolijn","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"26","key":"10.1016\/j.cardfail.2025.06.013_bib0182","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"25 Suppl 2","key":"10.1016\/j.cardfail.2025.06.013_bib0183","first-page":"S49","article-title":"2013 ACC\/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0184","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association's PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0185","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamainternmed.2024.1302","article-title":"Atherosclerotic cardiovascular disease risk estimates using the predicting risk of cardiovascular disease events equations","volume":"184","author":"Anderson","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.cardfail.2025.06.013_bib0186","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1161\/HYPERTENSIONAHA.124.22998","article-title":"Predicted cardiovascular risk by the PREVENT equations in US adults with stage 1 hypertension","volume":"81","author":"Muntner","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0187","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.100992","article-title":"Performance of PREVENT equations for cardiovascular risk prediction in young patients with myocardial infarction: From the MGB YOUNG-MI registry","volume":"22","author":"Singh","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0188","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.amjcard.2024.07.014","article-title":"Advancements in incident heart failure risk prediction and screening tools","volume":"227","author":"Matasic","year":"2024","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0189","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.039454","article-title":"Evaluation and comparison of the PREVENT and pooled cohort equations for 10-year atherosclerotic cardiovascular risk prediction","volume":"14","author":"Zhou","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"20","key":"10.1016\/j.cardfail.2025.06.013_bib0190","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (ckm) syndrome: a scientific statement From the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0191","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.cardfail.2025.06.013_bib0192","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.2020.21749","article-title":"Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US Preventive Services Task Force recommendation statement","volume":"324","author":"Krist","year":"2020","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.cardfail.2025.06.013_bib0193","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1161\/01.CIR.0000075572.40158.77","volume":"107","author":"Thompson","year":"2003","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.cardfail.2025.06.013_bib0194","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","article-title":"Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017","volume":"28","author":"Bragazzi","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"10.1016\/j.cardfail.2025.06.013_bib0195","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41569-018-0065-1","article-title":"Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors","volume":"15","author":"Fiuza-Luces","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0196","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jchf.2019.01.011","article-title":"Primary prevention of heart failure in women","volume":"7","author":"Daubert","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0197","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ejhf.1433","article-title":"Cardiorespiratory fitness, body mass index and heart failure incidence","volume":"21","author":"Kokkinos","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0198","first-page":"e4","article-title":"2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0199","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.tcm.2017.02.005","article-title":"The role of cardiac rehabilitation in patients with heart disease","volume":"27","author":"McMahon","year":"2017","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0200","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1840894","article-title":"Cost-effectiveness of cardiac rehabilitation in patients with coronary artery disease: a meta-analysis","volume":"2019","author":"Takura","year":"2019","journal-title":"Cardiol Res Pract"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0201","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0735-1097(93)90176-2","article-title":"Littman AB. Benefits of cardiac rehabilitation and exercise training in secondary coronary prevention in the elderly","volume":"22","author":"Lavie","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0202","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ahj.2006.05.015","article-title":"Clinical evidence for a health benefit from cardiac rehabilitation: an update","volume":"152","author":"Williams","year":"2006","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0203","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2021.01.030","article-title":"Cardiac rehabilitation for patients with heart failure: JACC Expert Panel","volume":"77","author":"Bozkurt","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0204","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11897-020-00462-2","article-title":"Cardiac rehab for functional improvement","volume":"17","author":"Epstein","year":"2020","journal-title":"Curr Heart Fail Rep"},{"issue":"12","key":"10.1016\/j.cardfail.2025.06.013_bib0205","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009403","article-title":"Cardiac Rehabilitation Among Hospitalized Patients With Heart Failure: Eligibility, Enrollment, and Participation","volume":"15","author":"Contractor","year":"2022","journal-title":"Circ Heart Fail"},{"issue":"14","key":"10.1016\/j.cardfail.2025.06.013_bib0206","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2009.457","article-title":"Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"Flynn","year":"2009","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0207","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jacc.2021.07.014","article-title":"Exercise intolerance in older adults with heart failure with preserved ejection fraction: JACC state-of-the-art review","volume":"78","author":"Pandey","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.cardfail.2025.06.013_bib0208","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jchf.2021.05.007","article-title":"Rehabilitation intervention in older patients with acute heart failure with preserved versus reduced ejection fraction","volume":"9","author":"Mentz","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"17","key":"10.1016\/j.cardfail.2025.06.013_bib0209","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/eurheartj\/ehad118","article-title":"Cardiac rehabilitation for heart failure: 'Cinderella' or evidence-based pillar of care?","volume":"44","author":"Taylor","year":"2023","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.cardfail.2025.06.013_bib0210","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.026472","article-title":"Disparities in geographic access to cardiac rehabilitation in Los Angeles County","volume":"11","author":"Ebinger","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0211","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jacc.2023.01.016","article-title":"Geographic variation in access to cardiac rehabilitation","volume":"81","author":"Duncan","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0212","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.cardfail.2025.06.013_bib0213","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"issue":"10333","key":"10.1016\/j.cardfail.2025.06.013_bib0214","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(22)00369-5","article-title":"Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial","volume":"399","author":"Ezekowitz","year":"2022","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.cardfail.2025.06.013_bib0215","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1108660","article-title":"Comparative effectiveness of weight-loss interventions in clinical practice","volume":"365","author":"Appel","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0216","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/jhh.2008.144","article-title":"A comprehensive review on salt and health and current experience of worldwide salt reduction programmes","volume":"23","author":"He","year":"2009","journal-title":"J Hum Hypertens"},{"issue":"16","key":"10.1016\/j.cardfail.2025.06.013_bib0217","first-page":"e240","article-title":"2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0218","first-page":"e1","article-title":"Guideline for the Management of Heart Failure","volume":"28","year":"2022","journal-title":"J Card Fail"},{"issue":"34","key":"10.1016\/j.cardfail.2025.06.013_bib0219","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jchf.2015.09.015","article-title":"Assessing the risk of progression from asymptomatic left ventricular dysfunction to overt heart failure: a systematic overview and meta-analysis","volume":"4","author":"Echouffo-Tcheugui","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0221","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.CIR.0000085166.44904.79","article-title":"Natural history of asymptomatic left ventricular systolic dysfunction in the community","volume":"108","author":"Wang","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0222","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ejhf.643","article-title":"Echocardiographic screening for non-ischaemic stage B heart failure in the community","volume":"18","author":"Yang","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0223","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure","volume":"306","author":"Kane","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0224","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jchf.2022.12.005","article-title":"Reclassification of pre-heart failure stages using cardiac biomarkers: the ARIC Study","volume":"11","author":"Jia","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0225","doi-asserted-by":"crossref","unstructured":"Goldenberg I, Ezekowitz J, Albert C, Alexis JD, Anderson L, Behr ER, et al. Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure. J Card Fail 2025;31(8):1326\u20131338.","DOI":"10.1016\/j.cardfail.2024.12.001"},{"issue":"12","key":"10.1016\/j.cardfail.2025.06.013_bib0226","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.cardfail.2025.06.013_bib0227","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.amjmed.2004.01.009","article-title":"Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials","volume":"116","author":"Taylor","year":"2004","journal-title":"Am J Med"},{"issue":"14","key":"10.1016\/j.cardfail.2025.06.013_bib0228","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"O'Connor","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0229","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41569-021-00611-7","article-title":"The role of cardiac rehabilitation in improving cardiovascular outcomes","volume":"19","author":"Taylor","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0230","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/2047487312449597","volume":"21","author":"Piepoli","year":"2014","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"10.1016\/j.cardfail.2025.06.013_bib0231","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12071604","article-title":"Impact of diabetes mellitus on outcomes in patients with left ventricular assist devices","volume":"12","author":"Crugnola","year":"2024","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.cardfail.2025.06.013_bib0232","first-page":"1661","article-title":"Obesity, challenges, and weight-loss strategies for patients with ventricular assist devices","volume":"12","author":"daSilva-deAbreu","year":"2024","journal-title":"JACC: Heart Failure"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0233","doi-asserted-by":"crossref","DOI":"10.1161\/HHF.0000000000000074","article-title":"Management of hypertension in patients with ventricular assist devices: a scientific statement from the American Heart Association","volume":"15","author":"Eisen","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0234","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2024.100114","article-title":"Glucagon-like peptide-1 agonist use for obesity treatment in patients with left ventricular assist devices","volume":"5","author":"Edwards","year":"2024","journal-title":"JHLT Open"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0235","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/aor.14942","article-title":"Glucagon-like peptide-1 receptor agonists in patients with durable left ventricular assist devices","volume":"49","author":"Elad","year":"2025","journal-title":"Artif Organs"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0236","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) Guidelines for the Care of Heart Transplant Recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0237","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.healun.2024.12.006","article-title":"Novel therapeutic agents for cardiometabolic risk mitigation in heart transplant recipients","volume":"44","author":"Gorrai","year":"2025","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0238","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.healun.2021.02.012","article-title":"Effects of GLP-1 receptor agonists and SGLT-2 inhibitors in heart transplant patients with type 2 diabetes: initial report from a cardiometabolic center of excellence","volume":"40","author":"Sammour","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0239","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/phar.2928","article-title":"The efficacy and safety of sodium-glucose cotransporter-2 inhibitors in solid organ transplant recipients: a scoping review","volume":"44","author":"Mreyoud","year":"2024","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0240","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/joim.20077","article-title":"Effects of SGLT2 inhibitors on transplant survival and key clinical outcomes in heart transplant recipients with diabetes","volume":"297","author":"Yen","year":"2025","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0241","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0242","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.102344","article-title":"Cardiovascular-kidney-metabolic (CKM) syndrome: a state-of-the-art review","volume":"49","author":"Sebastian","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0243","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5694\/mja2.50755","article-title":"Artificial intelligence in health care: preparing for the fifth Industrial Revolution","volume":"213","author":"Sung","year":"2020","journal-title":"Med J Aust"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0244","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5694\/mja2.50294","article-title":"Machine learning in clinical practice: prospects and pitfalls","volume":"211","author":"Scott","year":"2019","journal-title":"Med J Aust"},{"issue":"12","key":"10.1016\/j.cardfail.2025.06.013_bib0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260885","article-title":"Identification of patients at risk of new onset heart failure: Utilizing a large statewide health information exchange to train and validate a risk prediction model","volume":"16","author":"Duong","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0246","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcmg.2021.07.004","article-title":"Machine learning-derived echocardiographic phenotypes predict heart failure incidence in asymptomatic individuals","volume":"15","author":"Kobayashi","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.cardfail.2025.06.013_bib0247","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009303","article-title":"Automated echocardiographic quantification of left ventricular ejection fraction without volume measurements using a machine learning algorithm mimicking a human expert","volume":"12","author":"Asch","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0248","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jacc.2020.06.061","article-title":"Machine learning assessment of left ventricular diastolic function based on electrocardiographic features","volume":"76","author":"Kagiyama","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0249","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008081","article-title":"Machine learning methods improve prognostication, identify clinically distinct phenotypes, and detect heterogeneity in response to therapy in a large cohort of heart failure patients","volume":"7","author":"Ahmad","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.cardfail.2025.06.013_bib0250","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1016\/S2589-7500(23)00065-1","article-title":"Identifying subtypes of heart failure from three electronic health record sources with machine learning: an external, prognostic, and genetic validation study","volume":"5","author":"Banerjee","year":"2023","journal-title":"Lancet Digit Health"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0251","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024094","article-title":"Validation of the WATCH-DM and TRS-HF(DM) risk scores to predict the risk of incident hospitalization for heart failure among adults with type 2 diabetes: a multicohort analysis","volume":"11","author":"Segar","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2025.06.013_bib0252","doi-asserted-by":"crossref","unstructured":"Cheema B, Hourmozdi J, Kline A, Ahmad F, Khera R. Artificial Intelligence in the Management of Heart Failure. J Card Fail 2025.","DOI":"10.1016\/j.cardfail.2025.02.020"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0253","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41569-021-00522-7","article-title":"Smart wearable devices in cardiovascular care: where we are and how to move forward","volume":"18","author":"Bayoumy","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0254","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006513","article-title":"Continuous wearable monitoring analytics predict heart failure hospitalization: the LINK-HF multicenter study","volume":"13","author":"Stehlik","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0255","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/17434440.2023.2228683","article-title":"A profile on the CardioMEMS HF system in the management of patients with early stages of heart failure: an update","volume":"20","author":"Vyas","year":"2023","journal-title":"Expert Rev Med Devices"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0256","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis","volume":"67","author":"Anderson","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0257","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/HCR.0000000000000675","article-title":"Tracking cardiac rehabilitation utilization in Medicare beneficiaries: 2017 update","volume":"42","author":"Keteyian","year":"2022","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"1","key":"10.1016\/j.cardfail.2025.06.013_bib0258","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40615-018-0478-x","article-title":"Disparities in cardiac rehabilitation among individuals from racial and ethnic groups and rural communities\u2014a systematic review","volume":"6","author":"Castellanos","year":"2019","journal-title":"J Racial Ethn Health Disparities"},{"issue":"2","key":"10.1016\/j.cardfail.2025.06.013_bib0259","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030654","article-title":"Rationale and design of the mTECH\u2010Rehab randomized controlled trial: impact of a mobile technology enabled Corrie Cardiac Rehabilitation Program on functional status and cardiovascular health","volume":"13","author":"Isakadze","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0260","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028712","article-title":"Effect of adapted mindfulness training in participants with elevated office blood pressure: the MB-BP study: a randomized clinical trial","volume":"12","author":"Loucks","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0261","first-page":"217","article-title":"Spirituality in patients with heart failure","volume":"10","author":"Tobin Rachel","year":"2022","journal-title":"JACC: Heart Failure"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0262","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.psy.0000132872.71870.6d","article-title":"Cardiovascular reactivity to work stress predicts subsequent onset of hypertension: the Air Traffic Controller Health Change Study","volume":"66","author":"Ming","year":"2004","journal-title":"Psychosom Med"},{"issue":"3","key":"10.1016\/j.cardfail.2025.06.013_bib0263","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cardfail.2003.09.008","article-title":"Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure","volume":"10","author":"Joynt","year":"2004","journal-title":"J Card Fail"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0264","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: validity of a two-item depression screener","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.cardfail.2025.06.013_bib0265","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/JCN.0000000000000274","article-title":"A systematic review of relaxation, meditation, and guided imagery strategies for symptom management in heart failure","volume":"31","author":"Kwekkeboom","year":"2016","journal-title":"J Cardiovasc Nurs"},{"issue":"8","key":"10.1016\/j.cardfail.2025.06.013_bib0266","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1177\/1474515119863181","article-title":"Meditation interventions among heart failure patients: An integrative review","volume":"18","author":"Viveiros","year":"2019","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"17","key":"10.1016\/j.cardfail.2025.06.013_bib0267","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024974","article-title":"Religiosity\/spirituality and cardiovascular health: the American Heart Association Life's Simple 7 in African Americans of the Jackson Heart Study","volume":"11","author":"Brewer","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0268","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jchf.2022.01.014","article-title":"Spirituality in patients with heart failure","volume":"10","author":"Tobin","year":"2022","journal-title":"JACC Heart Fail"},{"issue":"36","key":"10.1016\/j.cardfail.2025.06.013_bib0269","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.cardfail.2025.06.013_bib0270","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.cardfail.2023.10.004","article-title":"#WordsMatter: supporting the rebranding of \"palliative care\" to \"supportive cardiology\" for patients living with heart failure","volume":"29","author":"Lala","year":"2023","journal-title":"J Card Fail"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0271","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cardfail.2022.03.001","article-title":"#WordsMatter continued: moving from \"candidacy\" to \"benefit derived\"","volume":"28","author":"Lala","year":"2022","journal-title":"J Card Fail"},{"issue":"4","key":"10.1016\/j.cardfail.2025.06.013_bib0272","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cardfail.2021.03.002","article-title":"Contemplation from our hearts: a call to shift from failure to function","volume":"27","author":"Lala","year":"2021","journal-title":"J Card Fail"},{"issue":"7","key":"10.1016\/j.cardfail.2025.06.013_bib0273","article-title":"JACC: Advances Expert Panel Perspective: Shared Decision-Making in Multidisciplinary Team-Based Cardiovascular Care","volume":"3","author":"Perpetua","year":"2024","journal-title":"JACC Adv"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425003276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425003276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:20:04Z","timestamp":1772778004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916425003276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":273,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1071916425003276"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.06.013","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. and Elsevier B.V.","name":"copyright","label":"Copyright"}]}}